
|
www.senology.org -
Newsletter
"Join the international senologic
and oncologic scientific
community" | | | | |
|
Gian Paolo Andreoletti, MD,
Editor-in-Chief - paolo.andreoletti@senology.it |
| Subscribe Unsubscribe
Contact Back
Issues www.senology.org / www.senology.it Home Page |
|

Literature Selection
-
Yang WT et al.: "Inflammatory breast cancer: PET/CT, MRI,
mammography, and sonography findings", Breast Cancer Res Treat.
2008 Jun;109(3):417-26
-
Emmering J et al.: "Preoperative
[18F] FDG-PET after chemotherapy in locally advanced breast
cancer: prognostic value as compared with histopathology", Ann
Oncol. 2008 Jun 13. [Epub ahead of print]
-
Poletti P et al.: "Axillary
recurrence in sentinel lymph node-negative breast cancer
patients", Ann Oncol. 2008 Jun 10. [Epub ahead of print]
-
Schaapveld M et al.: "The impact of
adjuvant therapy on contralateral breast cancer risk and the
prognostic significance of contralateral breast cancer: a
population based study in the Netherlands", Breast Cancer Res
Treat. 2008 Jul;110(1):189-97
-
Cheville AL et al.: "Prevalence and treatment patterns of
physical impairments in patients with metastatic breast cancer",
J Clin Oncol. 2008 Jun 1;26(16):2621-9
-
Collins B et al.: "Cognitive effects
of chemotherapy in post-menopausal breast cancer patients 1 year
after treatment.", Psychooncology. 2008 Jun 12. [Epub ahead of
print]
-
Buchholz TA et al.: "Radiation use and long-term survival in
breast cancer patients with t1, t2 primary tumors and one to
three positive axillary lymph nodes", Int J Radiat Oncol Biol
Phys. 2008 Jul 15;71(4):1022-7.
-
Stovall M et al.: "Dose to the
Contralateral Breast from Radiotherapy and Risk of Second
Primary Breast Cancer in the WECARE Study", Int J Radiat Oncol
Biol Phys. 2008 Jun 13. [Epub ahead of print]
-
Grady D et al.: "Reduced Incidence of
Invasive Breast Cancer With Raloxifene Among Women at Increased
Coronary Risk", J Natl Cancer Inst. 2008 Jun 10. [Epub ahead of
print]
-
Azim AA et al.: "Safety of fertility preservation by ovarian
stimulation with letrozole and gonadotropins in patients with
breast cancer: a prospective controlled study", J Clin Oncol.
2008 Jun 1;26(16):2630-5
-
Harrow A et al.: "Ambiguity and uncertainty: The ongoing
concerns of male partners of women treated for breast cancer",
Eur J Oncol Nurs. 2008 Jun 9. [Epub ahead of print]
-
Sprague BL et al.: "Proportion of Invasive Breast Cancer
Attributable to Risk Factors Modifiable after Menopause", Am J
Epidemiol. 2008 Jun 13. [Epub ahead of print]
-
Bertelsen L et al.: "Benign Breast Disease among First-Degree
Relatives of Young Breast Cancer Patients", Am J Epidemiol. 2008
Jun 4. [Epub ahead of print
Editorial
- "Removing 5 sentinel lymph
nodes is enough for accurate lymph node staging in the vast
majority of breast cancers" - Kelly K.
Hunt,
Surgical Breast Section, Department
of Surgical Oncology, M. D. Anderson Cancer Center, Houston, TX,
USA
"Our
study determines how many sentinel lymph nodes (SLNs) need to be
removed for accurate lymph node staging and which patient and
tumor characteristics influence this number.
Data from 777 patients with
at least 1 SLN that was positive
for cancer have been collected in this retrospective
study. The mean number of SLNs
removed in the 777 lymph node-positive patients was 2.9 (range,
1-13 SLNs). Greater than 99% of positive SLNs were identified in
the first 5 lymph nodes removed. On multivariate analysis, mixed
ductal and lobular histology, Caucasian race, inner quadrant
tumor location, and T1 tumor classification significantly
increased the number of SLNs that needed to be removed to
achieve 99% recovery of all positive SLNs. In general, the
removal of a maximum of 5 SLNs at surgery allowed for the
recovery of >99% of positive SLNs in patients with breast
cancer. Tumor histology, patient race, and tumor size and
location may influence this number" (Comment on paper:
Yi M et al.: "How many sentinel lymph nodes are enough during
sentinel lymph node dissection for breast cancer?", Cancer. 2008
[Epub ahead of print])
Press Releases
Video and Lectures
Calendar of Events
- Breast Cancer in Young Women
Symposium, July 3, 2008, Lugano, Switzerland - During the ECLU 2008
Conference
- Seventh
International Congress on the Future of Breast Cancer, July 23-26,
2008, Koloa, Hi, USA
-
2008 Breast Cancer Symposium, Sep 5-7, 2008, Washington, DC, USA

Literature Selection
Press Releases
-
"Symptom screening plus a simple blood test equals a 20 percent
jump in early detection of ovarian cancer" - Fred Hutchinson Cancer Research Center, Seattle, WA,
USA - www.fhcrc.org
-
"Patient's own infection-fighting T cells put late-stage
melanoma into long-term remission — without chemotherapy or
radiation" - Fred Hutchinson Cancer Research Center, Seattle, WA,
USA - www.fhcrc.org
-
"Acupuncture
Reduces Pain and Dysfunction in Head and Neck Cancer Patients
after Neck Dissection" - Memorial
Sloan-Kettering Cancer Center, New York, USA -
www.mskcc.org
-
"Research explains how advanced prostate cancer becomes
resistant to androgen-deprivation therapy - Findings suggest
androgen production occurs within metastatic prostate tumors"
- Fred Hutchinson Cancer Research Center, Seattle, WA,
USA - www.fhcrc.org
Clinical Guidelines
 Literature Selection
Editorial
- "Changed cytokine patterns
in the breast milk during inflammatory breast diseases and their
side effects for the newborn" -
Achim Wöckel,
Department of Gynecology and Obstetrics, University
Hospital Ulm, Ulm, Germany
"Despite
a surge of evidence on the benefits of breastfeeding for mothers
and the newborns there is a lack of valid and empirical data on
lactation-related inflammatory breast diseases, which are also
the most common reason for early weaning. Additionally there is
also only little research on collateral effects of these
puerperal diseases. But inflammatory breast diseases during
lactation, like milk stasis or puerperal mastitis, cause a
modulation of cytokine levels in breast milk. This imbalance of
cytokines in breast milk may have severe consequences for the
newborn, which in turn affects the child's development. In our
systematic review all important studies and possible health
effects for the childs are summarized with regard to different
cytokines. Until now proceeding of breastfeeding is recommended
also during theses inflammatory breast diseases, but we have to
consider these side effects for the newborn in the future and
need further investigations to analyze the correlations" (Comment on
paper:
Wockel A et al.: "Inflammatory breast
diseases during lactation: health effects on the newborn-a
literature review", Mediators Inflamm. 2008;2008:298760)
Happy Holidays!
|
Educational Grants - Sincere
appreciation is extended to the following companies for their
generous support of this activity: -
Roche -
AstraZeneca
If this e-mail has reached you in
error, simply click on the following link and unsubscribe
yourself: Unsubscribe
Contact info - For
advertising information please contact: A&B@senology.it . For other enquiries, problems or
suggestions please contact: staff@senology.it
© A&B Edizioni
Medico-Scientifiche - Milan, Italy. Fax:
+39.035.7171000 | |